Robert Moreau

Robert Moreau has a strong background in biomedical research, starting with their role as a Research Investigator I at GNF from March 2009 to June 2013. Robert then joined Novartis Institutes for BioMedical Research (NIBR) in July 2013 as an Investigator II, where they worked until August 2015. From September 2015 to April 2018, they served as an Investigator III at NIBR before being promoted to Senior Investigator I in May 2018. In May 2021, Robert joined Interline Therapeutics as an Associate Director, where they currently work.

Robert Moreau earned an AB degree in Chemistry from the College of the Holy Cross between 1998 and 2002. Robert then pursued a PhD in Synthetic Organic Chemistry, first as a PhD candidate at Scripps Research from 2002 to 2003, and later at Princeton University, where they completed their PhD between 2003 and 2009.